Skip to main content
FinSpry Logo
FinSpry
MPLT logo
MPLT
(NASDAQ)
MapLight Therapeutics, Inc.
$13.79-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

MapLight Therapeutics, Inc. (MPLT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for MapLight Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(8 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$40.00
↑ 190.17% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest MPLT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Unknown Analyst
Jefferies
BuyMaintains
$25.00
Ami Fadia
Needham
BuyMaintains
$42.00 → $45.00
Francois Brisebois
LifeSci Capital
BuyMaintains
$45.00
Tiago Fauth
Raymond James
BuyInitiates
$46.00
Adam Vogel
Craig-Hallum
BuyMaintains
$43.00 → $40.00
Sean Laaman
Morgan Stanley
BuyReiterates
$34.00
Ram Selvaraju
HC Wainwright
BuyReiterates
$45.00
Ami Fadia
Needham
BuyReiterates
$37.00 → $42.00

Frequently Asked Questions

What is the analyst consensus rating for MPLT?

The analyst consensus rating for MPLT is "Buy" based on 7 analyst recommendations.

What is the average price target for MPLT?

The average 12-month price target for MPLT is $40.00, representing an upside of 190.2% from the current price of $13.79.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.